A phase II clinical study involving 27 patients who experienced septic shock and severe lymphopenia demonstrated that IL-7 therapy led to considerable increases in the counts of CD4+ and CD8+ T lymphocytes without producing an excessive inflammatory response or increased organ dysfunction [227]. The gene discussed is IL7; the disease is lymphopenia.